← FDA DRUG APPROVALS

FDA NDA · NDA020091

IMAGENT

Sponsor: ALLIANCE PHARM

APPLICATION
NDA020091
TYPE
NDA
ORIGINAL APPROVAL
1993-08-13
LATEST ACTION
1996-08-27
ROUTE
ORAL
DOSAGE FORM
LIQUID
MARKETING STATUS
Discontinued

Products

IMAGENTDiscontinued
PERFLUBRON 100% · LIQUID · ORAL

Approval history

1996-08-27Manufacturing (CMC) · Supplement 5 · priorityAP
1995-03-29Manufacturing (CMC) · Supplement 4 · priorityAP
1994-09-30Manufacturing (CMC) · Supplement 3 · priorityAP
1994-09-30Manufacturing (CMC) · Supplement 2 · priorityAP
1993-09-22Labeling · Supplement 1 · standardAP
1993-08-13Type 1 - New Molecular Entity · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →